Novartis Loses Landmark India Patent Case on Glivec

"India's top court rejected Swiss drugmaker Novartis AG's plea for patent protection of its cancer drug Glivec," reports the Chicago Tribune , "a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals." The country's Supreme Court has established a legal precedent that does not favor patents on existing drugs ... (more)

http://www.nacdonline.org/Resources/RSSDetail.cfm?RSSID=69555